EssilorLuxottica Société anonyme (ESLOY)
USD 120.32
(-1.55%)
USD 120.32
(-1.55%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 11.65 Billion EUR | -4.48% |
| 2022 | 12.2 Billion EUR | -6.25% |
| 2021 | 13.01 Billion EUR | 9.43% |
| 2020 | 11.89 Billion EUR | 26.34% |
| 2019 | 9.41 Billion EUR | 149.93% |
| 2018 | 3.76 Billion EUR | 74.0% |
| 2017 | 2.16 Billion EUR | -17.05% |
| 2016 | 2.61 Billion EUR | 1.2% |
| 2015 | 2.57 Billion EUR | 5.39% |
| 2014 | 2.44 Billion EUR | 108.43% |
| 2013 | 1.17 Billion EUR | 28.13% |
| 2012 | 916.24 Million EUR | 0.06% |
| 2011 | 915.73 Million EUR | 33.03% |
| 2010 | 688.39 Million EUR | 88.52% |
| 2009 | 365.15 Million EUR | -43.86% |
| 2008 | 650.45 Million EUR | 39.11% |
| 2007 | 467.57 Million EUR | 3.9% |
| 2006 | 450 Million EUR | -25.63% |
| 2005 | 605.07 Million EUR | -6.34% |
| 2004 | 646.05 Million EUR | -8.88% |
| 2003 | 709.03 Million EUR | 70.63% |
| 2002 | 415.55 Million EUR | -0.45% |
| 2001 | 417.42 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 11.07 Billion EUR | -5.01% |
| 2024 Q2 | 8.41 Billion EUR | 7.68% |
| 2023 Q2 | 11.74 Billion EUR | 7.7% |
| 2023 Q1 | 10.9 Billion EUR | -10.63% |
| 2023 Q4 | 11.65 Billion EUR | 7.78% |
| 2023 Q3 | 10.81 Billion EUR | -7.93% |
| 2023 FY | 11.65 Billion EUR | -4.48% |
| 2022 Q3 | 11.35 Billion EUR | -19.94% |
| 2022 Q4 | 12.2 Billion EUR | 7.45% |
| 2022 Q1 | 13.32 Billion EUR | 2.37% |
| 2022 FY | 12.2 Billion EUR | -6.25% |
| 2022 Q2 | 14.18 Billion EUR | 6.46% |
| 2021 FY | 13.01 Billion EUR | 9.43% |
| 2021 Q1 | 10.91 Billion EUR | -8.22% |
| 2021 Q4 | 13.01 Billion EUR | 6.88% |
| 2021 Q2 | 11.41 Billion EUR | 4.54% |
| 2021 Q3 | 12.17 Billion EUR | 6.71% |
| 2020 FY | 11.89 Billion EUR | 26.34% |
| 2020 Q3 | 11.36 Billion EUR | -8.56% |
| 2020 Q1 | 11.84 Billion EUR | 25.78% |
| 2020 Q4 | 11.89 Billion EUR | 4.64% |
| 2020 Q2 | 12.43 Billion EUR | 4.98% |
| 2019 Q1 | 5.81 Billion EUR | 54.26% |
| 2019 FY | 9.41 Billion EUR | 149.93% |
| 2019 Q3 | 8.88 Billion EUR | 41.14% |
| 2019 Q4 | 9.41 Billion EUR | 5.95% |
| 2019 Q2 | 6.29 Billion EUR | 8.35% |
| 2018 Q2 | 2.51 Billion EUR | 0.0% |
| 2018 FY | 3.76 Billion EUR | 74.0% |
| 2018 Q4 | 3.76 Billion EUR | -27.85% |
| 2018 Q3 | 5.22 Billion EUR | 107.43% |
| 2018 Q1 | 2.51 Billion EUR | 16.26% |
| 2017 Q4 | 2.16 Billion EUR | 14.67% |
| 2017 Q3 | 1.88 Billion EUR | -34.1% |
| 2017 Q2 | 2.86 Billion EUR | 0.0% |
| 2017 Q1 | 2.86 Billion EUR | 9.77% |
| 2017 FY | 2.16 Billion EUR | -17.05% |
| 2016 Q2 | 2.67 Billion EUR | 0.0% |
| 2016 FY | 2.61 Billion EUR | 1.2% |
| 2016 Q1 | 2.67 Billion EUR | 3.57% |
| 2016 Q3 | 2.6 Billion EUR | -2.4% |
| 2016 Q4 | 2.61 Billion EUR | 0.12% |
| 2015 Q3 | 2.57 Billion EUR | -6.36% |
| 2015 FY | 2.57 Billion EUR | 5.39% |
| 2015 Q2 | 2.75 Billion EUR | 0.0% |
| 2015 Q4 | 2.57 Billion EUR | 0.16% |
| 2015 Q1 | 2.75 Billion EUR | 12.38% |
| 2014 Q2 | 2.84 Billion EUR | 0.0% |
| 2014 FY | 2.44 Billion EUR | 108.43% |
| 2014 Q3 | 2.44 Billion EUR | -14.03% |
| 2014 Q4 | 2.44 Billion EUR | 0.08% |
| 2014 Q1 | 2.84 Billion EUR | 142.25% |
| 2013 Q1 | 992.37 Million EUR | 8.31% |
| 2013 Q4 | 1.17 Billion EUR | 0.0% |
| 2013 Q3 | 1.17 Billion EUR | 18.3% |
| 2013 Q2 | 992.37 Million EUR | 0.0% |
| 2013 FY | 1.17 Billion EUR | 28.13% |
| 2012 Q4 | 916.24 Million EUR | 0.0% |
| 2012 Q2 | 1.17 Billion EUR | 0.0% |
| 2012 FY | 916.24 Million EUR | 0.06% |
| 2011 FY | 915.73 Million EUR | 33.03% |
| 2011 Q2 | 875.24 Million EUR | 0.0% |
| 2011 Q4 | 915.73 Million EUR | 0.0% |
| 2010 Q2 | 996.26 Million EUR | 0.0% |
| 2010 FY | 688.39 Million EUR | 88.52% |
| 2010 Q4 | 688.39 Million EUR | 0.0% |
| 2009 Q4 | 365.15 Million EUR | 0.0% |
| 2009 FY | 365.15 Million EUR | -43.86% |
| 2008 FY | 650.45 Million EUR | 39.11% |
| 2007 FY | 467.57 Million EUR | 3.9% |
| 2006 FY | 450 Million EUR | -25.63% |
| 2005 FY | 605.07 Million EUR | -6.34% |
| 2004 FY | 646.05 Million EUR | -8.88% |
| 2003 FY | 709.03 Million EUR | 70.63% |
| 2002 FY | 415.55 Million EUR | -0.45% |
| 2001 FY | 417.42 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 500 Thousand USD | -2331300.0% |
| Ansell Limited | 855.59 Million USD | -1262.443% |
| Ansell Limited | 857.2 Million USD | -1259.893% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 22.41 Million USD | -51913.329% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 20.93 Thousand USD | -55681772.462% |
| Psykey, Inc. | 1.01 Million USD | -1153373.184% |
| ConvaTec Group Plc | 1.31 Billion USD | -789.476% |
| ConvaTec Group Plc | 1.31 Billion USD | -788.22% |
| Encision Inc. | 1.33 Million USD | -874261.125% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -504812.469% |
| Innovative MedTech Inc. | 1.87 Million USD | -620539.167% |
| LifePoint, Inc. | 446.74 Thousand USD | -2609247.719% |
| Medite Cancer Diagnostics, Inc. | 5.39 Million USD | -216003.202% |
| Paradigm Medical Industries, Inc. | 2.18 Million USD | -532426.268% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | - USD | -Infinity% |
| Reflect Scientific, Inc. | 242.64 Thousand USD | -4804057.531% |
| SmileDirectClub, Inc. | 871.79 Million USD | -1237.123% |
| Sector 10, Inc. | 164 Thousand USD | -7107826.829% |
| Shandong Weigao Group Medical Polymer Company Limited | 674.01 Million USD | -1629.495% |
| SheerVision, Inc. | 75 Thousand USD | -15542566.667% |
| United Health Products, Inc. | 755.98 Thousand USD | -1541853.653% |
| Vasamed, Inc. | 23.45 Thousand USD | -49709921.322% |
| Wearable Health Solutions, Inc. | 2.76 Million USD | -421130.266% |
| Yubo International Biotech Limited | 790.49 Thousand USD | -1474538.172% |